Factdock Insights

Official announcements and work in progress, gathered every day from the institutions that publish them first — and written in 38 languages for researchers, veterinarians, analysts and professionals.

Share
Live · 135 primary institutions monitored dailyUpdated · 2026-09-20 22:10 UTC
Today’s lead story

Specialised Therapeutics Expands Partnership with Incyte to Include Ruxolitinib Cream (Opzelura®) in Australia

SINGAPORE, Sept. 20, 2026 /PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics (ST) today announced an expansion of its existing partnership with Incyte Biosciences International, an affiliate of Incyte (NASDAQ: INCY), to commercialise, distribute, and register...

Energy & climatePipeline & developmentPR Newswire (Health)
Read the source

Nine fields, refreshed every day. Open a field for its newest official records and pipeline updates.

IP & patentsPipeline & developmentPR Newswire (Venture Capital)US

S2S China Announces 2026 Finalists, Ten Standout Teams Set to Pitch Global Investors at Westlake University

SHANGHAI, Sept. 20, 2026 /PRNewswire/ -- The inaugural S2S China Symposium has announced the finalists of its 2026 program. Co-hosted by RA Capital Management and Qiming Venture Partners, S2S China is the China chapter of Science2Startup, an invitation-only symposium connecting top...

Read the source

The latest in each field

Read every record in your own language

This page shows the three newest items per field. Members see every record in the field, in 109 languages, with the search engines that work on them.

Read it in full for $29

No app-store installation. Cancel any time.

Every item links to the institution that published it. Nothing is rewritten without its source.